Authors: McKenna, F Borenstein, D Wendt, H Wallemark, C Lefkowith, JB Geis, GS

Citation: F. Mckenna et al., Celecoxib versus diclofenac in the management of osteoarthritis of the knee - A placebo-controlled, randomised, double-blind comparison, SC J RHEUM, 30(1), 2001, pp. 11-18

Authors: Lefkowith, JB Geis, GS Silverstein, F

Citation: Jb. Lefkowith et al., Safety of celecoxib vs other nonsteroidal anti-inflammatory drugs - Reply, J AM MED A, 284(24), 2000, pp. 3123-3124

Authors: Silverstein, FE Faich, G Goldstein, JL Simon, LS Pincus, T Whelton, A Makuch, R Eisen, G Agarwal, NM Stenson, WF Burr, AM Zhao, WW Kent, JD Lefkowith, JB Verburg, KM Geis, GS

Citation: Fe. Silverstein et al., Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatorydrugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial, J AM MED A, 284(10), 2000, pp. 1247-1255

Authors: Simon, LS Zhao, SZ Arguelles, LM Lefkowith, JB Dedhiya, SD Fort, JG Johnson, KE

Citation: Ls. Simon et al., Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis, CLIN THER, 20(6), 1998, pp. 1218-1235